Oxethazaine

Oxethazaine (Oxetacaine), a precursor of phentermine acidic, is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated with peptic ulcer disease or esophagitis[1].

Product Specifications

CAS Number

[126-27-2]

Product Name Alternative

Oxetacaine

UNSPSC

12352005

Hazard Statement

H302

Target

HBV

Type

Reference compound

Related Pathways

Anti-infection

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/Oxethazaine.html

Concentration

10mM

Purity

99.94

Solubility

DMSO : ≥ 50 mg/mL

Smiles

OCCN(CC(N(C(C)(C)CC1=CC=CC=C1)C)=O)CC(N(C(C)(C)CC2=CC=CC=C2)C)=O

Molecular Formula

C28H41N3O3

Molecular Weight

467.64

Precautions

H302

References & Citations

[1]SEIFTER J, ET AL. Oxethazaine and related congeners: a series of highly potent local anesthetics. Proc Soc Exp Biol Med. 1962 Mar;109:664-8.|[2]Soo-Yeun Lee, et al. The abuse potential of oxethazaine: Effects of oxethazaine on drug-seeking behavior and analysis of its metabolites in plasma and hair in animal models. Pharmacology, Biochemistry and Behavior